JP2013536195A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013536195A5 JP2013536195A5 JP2013524318A JP2013524318A JP2013536195A5 JP 2013536195 A5 JP2013536195 A5 JP 2013536195A5 JP 2013524318 A JP2013524318 A JP 2013524318A JP 2013524318 A JP2013524318 A JP 2013524318A JP 2013536195 A5 JP2013536195 A5 JP 2013536195A5
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- chelate complex
- pharmaceutical composition
- complex comprises
- chelate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37525710P | 2010-08-20 | 2010-08-20 | |
| US61/375,257 | 2010-08-20 | ||
| PCT/CA2011/000956 WO2012021985A1 (en) | 2010-08-20 | 2011-08-18 | Oligonucleotide chelate complexes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013536195A JP2013536195A (ja) | 2013-09-19 |
| JP2013536195A5 true JP2013536195A5 (https=) | 2014-04-10 |
| JP5775581B2 JP5775581B2 (ja) | 2015-09-09 |
Family
ID=45594559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524318A Active JP5775581B2 (ja) | 2010-08-20 | 2011-08-18 | オリゴヌクレオチドキレート錯体 |
Country Status (35)
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007282224B2 (en) | 2006-08-11 | 2013-08-29 | Vico Therapeutics B.V. | Methods and means for treating DNA repeat instability associated genetic disorders |
| CA2723672C (en) | 2007-05-11 | 2019-09-03 | Adynxx, Inc. | Gene expression and pain |
| AU2008317566B2 (en) | 2007-10-26 | 2014-05-01 | Academisch Ziekenhuis Leiden | Means and methods for counteracting muscle disorders |
| EP2119783A1 (en) | 2008-05-14 | 2009-11-18 | Prosensa Technologies B.V. | Method for efficient exon (44) skipping in Duchenne Muscular Dystrophy and associated means |
| CN112251436A (zh) | 2012-01-27 | 2021-01-22 | 比奥马林技术公司 | 治疗杜兴型肌营养不良症和贝克型肌营养不良症的具有改善特性的rna调节性寡核苷酸 |
| SMT201700339T1 (it) | 2012-04-23 | 2017-09-07 | Biomarin Tech Bv | Oligonucleotidi di modulazione dell'rna con caratteristiche migliorate per il trattamento dei disturbi neuromuscolari |
| EP3511022A1 (en) * | 2012-05-10 | 2019-07-17 | Adynxx, Inc. | Formulations for the delivery of active ingredients |
| MY168778A (en) * | 2012-05-18 | 2018-12-04 | Replicor Inc | Oligonucleotide chelate complex-polypeptide compositions and methods |
| AR091065A1 (es) * | 2012-05-18 | 2014-12-30 | Replicor Inc | Una formulacion farmaceutica que comprende un quelato de oligonucleotidos antiviral para el tratamiento de una infeccion antiviral |
| EP2870246B1 (en) | 2012-07-03 | 2019-09-11 | BioMarin Technologies B.V. | Oligonucleotide for the treatment of muscular dystrophy patients |
| AU2013308045B2 (en) * | 2012-08-30 | 2018-10-04 | Replicor Inc. | Methods for the treatment of hepatitis B and hepatitis D infections |
| HRP20231400T1 (hr) | 2014-07-10 | 2024-02-16 | Replicor Inc. | Kelirani fosforotioirani polimeri nukleinskih kiselina, namijenjeni upotrebi u kombinaciji s inhibitorom hbv polimeraze u liječenju infekcija virusima hepatitisa b i hepatitisa d |
| JP6705807B2 (ja) | 2014-08-15 | 2020-06-03 | エーダイニクス インコーポレイテッド | 疼痛を治療するためのオリゴヌクレオチドデコイ |
| WO2016030863A1 (en) | 2014-08-29 | 2016-03-03 | Glaxosmithkline Intellectual Property Development Limited | Compounds and methods for treating viral infections |
| AU2016250576C1 (en) * | 2015-04-23 | 2021-05-06 | Geron Corporation | Methods of polynucleotide preparation using multivalent cation salt compositions |
| US11166976B2 (en) | 2018-11-08 | 2021-11-09 | Aligos Therapeutics, Inc. | S-antigen transport inhibiting oligonucleotide polymers and methods |
| PE20211783A1 (es) * | 2018-11-08 | 2021-09-08 | Aligos Therapeutics Inc | Polimeros oligonucleotidos que inhiben el transporte de antigenos y metodos |
| WO2021198958A1 (en) | 2020-04-01 | 2021-10-07 | Janssen Biopharma, Inc. | Nucleic acid polymers |
| WO2022109129A1 (en) * | 2020-11-20 | 2022-05-27 | Aligos Therapeutics, Inc. | Conjugates of s-antigen transport inhibiting oligonucleotide polymers having enhanced liver targeting |
| TW202245809A (zh) | 2020-12-18 | 2022-12-01 | 美商詹森藥物公司 | 用於治療b型肝炎病毒感染之組合療法 |
| WO2022152869A1 (en) | 2021-01-15 | 2022-07-21 | Janssen Sciences Ireland Unlimited Company | Use of oligonucleotides for individuals with hepatic impairment |
| EP4367241A1 (en) | 2021-07-09 | 2024-05-15 | GlaxoSmithKline Intellectual Property (No.3) Limited | Use of oligonucleotides for individuals with renal impairment |
| EP4728073A1 (en) * | 2023-06-16 | 2026-04-22 | Ractigen Therapeutics | Oligonucleotide formulation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001514873A (ja) * | 1997-08-20 | 2001-09-18 | ソーマジェニックス インコーポレイテッド | 結合特性が改善されたアンチセンスおよびアンチジーン治療薬並びにそれらの使用方法 |
| JP3667047B2 (ja) * | 1997-09-12 | 2005-07-06 | キヤノン株式会社 | 人工核酸およびその製造方法、デオキシリボフラノース化合物、リボフラノース化合物およびこれらの製造方法 |
| US6653467B1 (en) * | 2000-04-26 | 2003-11-25 | Jcr Pharmaceutical Co., Ltd. | Medicament for treatment of Duchenne muscular dystrophy |
| JP4836366B2 (ja) * | 2000-08-25 | 2011-12-14 | 雅文 松尾 | デュシェンヌ型筋ジストロフィー治療剤 |
| US20070105116A1 (en) | 2003-09-02 | 2007-05-10 | Japan Science And Technology Agency | Metal complex type nucleic acid |
| WO2005026188A1 (ja) | 2003-09-08 | 2005-03-24 | Japan Science And Technology Agency | 金属錯体型核酸 |
| JP2009500020A (ja) * | 2005-07-01 | 2009-01-08 | バイオヴェリス コーポレイション | 核酸を検出、増幅および／また単離するための組成物および方法 |
| WO2009065181A1 (en) * | 2007-11-21 | 2009-05-28 | Apollo Life Sciences Limited | Nanostructures suitable for delivery of agents |
-
2011
- 2011-08-18 BR BR112013003875-6A patent/BR112013003875B1/pt not_active IP Right Cessation
- 2011-08-18 RS RS20160869A patent/RS55245B1/sr unknown
- 2011-08-18 KR KR1020137007008A patent/KR101606495B1/ko not_active Expired - Fee Related
- 2011-08-18 EA EA201300259A patent/EA026660B1/ru unknown
- 2011-08-18 KR KR20157007582A patent/KR20150039873A/ko not_active Withdrawn
- 2011-08-18 CA CA2806616A patent/CA2806616C/en active Active
- 2011-08-18 LT LTEP11817618.9T patent/LT2605794T/lt unknown
- 2011-08-18 MY MYPI2013000544A patent/MY160961A/en unknown
- 2011-08-18 MX MX2013001668A patent/MX340294B/es active IP Right Grant
- 2011-08-18 ES ES11817618.9T patent/ES2598556T3/es active Active
- 2011-08-18 SG SG2013004957A patent/SG187165A1/en unknown
- 2011-08-18 WO PCT/CA2011/000956 patent/WO2012021985A1/en not_active Ceased
- 2011-08-18 CN CN201410046103.1A patent/CN103768086B/zh active Active
- 2011-08-18 DK DK11817618.9T patent/DK2605794T3/en active
- 2011-08-18 PT PT118176189T patent/PT2605794T/pt unknown
- 2011-08-18 PH PH1/2013/500192A patent/PH12013500192B1/en unknown
- 2011-08-18 HR HRP20161333TT patent/HRP20161333T1/hr unknown
- 2011-08-18 KR KR1020157017340A patent/KR20150082685A/ko not_active Withdrawn
- 2011-08-18 AU AU2011291401A patent/AU2011291401B2/en not_active Ceased
- 2011-08-18 PL PL11817618T patent/PL2605794T3/pl unknown
- 2011-08-18 EP EP11817618.9A patent/EP2605794B1/en active Active
- 2011-08-18 CA CA2855690A patent/CA2855690C/en active Active
- 2011-08-18 JP JP2013524318A patent/JP5775581B2/ja active Active
- 2011-08-18 SI SI201130985A patent/SI2605794T1/sl unknown
- 2011-08-18 HU HUE11817618A patent/HUE029521T2/en unknown
- 2011-08-18 US US13/212,306 patent/US8513211B2/en active Active
- 2011-08-18 NZ NZ606364A patent/NZ606364A/en not_active IP Right Cessation
- 2011-08-18 CN CN201180035946.6A patent/CN103052405B/zh active Active
-
2013
- 2013-01-15 IL IL224237A patent/IL224237A/en active IP Right Grant
- 2013-01-18 ZA ZA2013/00497A patent/ZA201300497B/en unknown
- 2013-02-11 CO CO13027675A patent/CO6670525A2/es unknown
- 2013-02-13 CL CL2013000445A patent/CL2013000445A1/es unknown
- 2013-02-14 GT GT201300040A patent/GT201300040A/es unknown
- 2013-02-14 DO DO2013000041A patent/DOP2013000041A/es unknown
- 2013-02-19 CR CR20130069A patent/CR20130069A/es unknown
- 2013-02-19 EC ECSP13012449 patent/ECSP13012449A/es unknown
- 2013-02-20 CU CU2013000022A patent/CU20130022A7/es unknown
- 2013-05-30 US US13/905,318 patent/US8716259B2/en active Active
-
2016
- 2016-10-13 SM SM201600370T patent/SMT201600370B/it unknown
- 2016-10-17 CY CY20161101037T patent/CY1118207T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013536195A5 (https=) | ||
| PH12013500192B1 (en) | Oligonucleotide chelate complexes | |
| Živec et al. | Different types of copper complexes with the quinolone antimicrobial drugs ofloxacin and norfloxacin: Structure, DNA-and albumin-binding | |
| IL316808A (en) | Modified double-stranded RNA materials and their uses | |
| JP2016512230A5 (https=) | ||
| JP2013507415A5 (https=) | ||
| JP2014521735A5 (https=) | ||
| JP2013532729A5 (https=) | ||
| US9370535B2 (en) | Method for treatment of advanced solid tumors | |
| ME02321B (me) | Antivirusna jedinjenja | |
| JP2014510729A5 (https=) | ||
| MX2010004089A (es) | Compuestos metalicos mezclados para el tratamiento de hiperfosfatemia. | |
| AU2012245080B2 (en) | A method for the treatment of a solid tumour | |
| SI2268292T1 (en) | Method and compositions for the treatment of cancer | |
| HRP20200822T1 (hr) | Pripravci i postupci za inhibiciju ekspresije gena alas1 | |
| CA2672839A1 (en) | Treatment of lung cancer with s-farnesylthiosalicylic acid and analogs thereof | |
| JP2014530181A5 (https=) | ||
| Douillard et al. | Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel–cisplatin versus vinorelbine–cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study | |
| JP2013544892A5 (https=) | ||
| JP2012504584A5 (https=) | ||
| WO2011031890A4 (en) | Cancer stem cell-targeted and drug resistant cancer therapy | |
| JP2011507839A5 (https=) | ||
| WO2012040164A3 (en) | Tlr5 ligands, therapeutic methods, and compositions related thereto | |
| WO2009096245A1 (ja) | 医薬組成物又は組合せ剤 | |
| JP6758195B2 (ja) | 併用ベースの治療方法 |